WO2020111951A1 - Diffuseur pour composant d'un système de thérapie respiratoire - Google Patents

Diffuseur pour composant d'un système de thérapie respiratoire Download PDF

Info

Publication number
WO2020111951A1
WO2020111951A1 PCT/NZ2019/050154 NZ2019050154W WO2020111951A1 WO 2020111951 A1 WO2020111951 A1 WO 2020111951A1 NZ 2019050154 W NZ2019050154 W NZ 2019050154W WO 2020111951 A1 WO2020111951 A1 WO 2020111951A1
Authority
WO
WIPO (PCT)
Prior art keywords
vent
mask assembly
diffuser
diffuser material
localised joint
Prior art date
Application number
PCT/NZ2019/050154
Other languages
English (en)
Inventor
Hamish Joshua ROSE
Nigel TRINIDADE
Original Assignee
Fisher & Paykel Healthcare Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fisher & Paykel Healthcare Limited filed Critical Fisher & Paykel Healthcare Limited
Priority to SG11202104824UA priority Critical patent/SG11202104824UA/en
Priority to US17/309,381 priority patent/US20220023569A1/en
Priority to EP19890824.6A priority patent/EP3886957A4/fr
Priority to AU2019388414A priority patent/AU2019388414A1/en
Publication of WO2020111951A1 publication Critical patent/WO2020111951A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/06—Respiratory or anaesthetic masks
    • A61M16/0605—Means for improving the adaptation of the mask to the patient
    • A61M16/0633—Means for improving the adaptation of the mask to the patient with forehead support
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/06—Respiratory or anaesthetic masks
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/08—Bellows; Connecting tubes ; Water traps; Patient circuits
    • A61M16/0816—Joints or connectors
    • A61M16/0825—Joints or connectors with ball-sockets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/20—Valves specially adapted to medical respiratory devices
    • A61M16/208—Non-controlled one-way valves, e.g. exhalation, check, pop-off non-rebreathing valves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/0003—Accessories therefor, e.g. sensors, vibrators, negative pressure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/08—Bellows; Connecting tubes ; Water traps; Patient circuits
    • A61M16/0816—Joints or connectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/02—Gases
    • A61M2202/0225—Carbon oxides, e.g. Carbon dioxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/02—General characteristics of the apparatus characterised by a particular materials
    • A61M2205/0216—Materials providing elastic properties, e.g. for facilitating deformation and avoid breaking
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/33—Controlling, regulating or measuring
    • A61M2205/3331—Pressure; Flow
    • A61M2205/3341—Pressure; Flow stabilising pressure or flow to avoid excessive variation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/42—Reducing noise

Definitions

  • the present disclosure generally relates to a diffuser for use with, or comprising part of, a component of a respiratory therapy system, for diffusing gases from a patient interface of the system.
  • a respiratory therapy system is for the treatment of obstructive sleep apnea (OSA) by continuous positive airway pressure (CPAP) or bi-level positive airway pressure (BiPAP) flow generator systems involving the delivery of pressurized gases to the air-ways of a human via a conduit and a patient interface.
  • CPAP continuous positive airway pressure
  • BiPAP bi-level positive airway pressure
  • Such a patient interface may be any one of the following: a) a nasal interface configured to seal around the nares or nose of the patient; b) an oral mask configured to seal around the mouth of the patient; or c) a full face (or oro-nasal) mask configured to seal around both the mouth and nose of the patient.
  • the patient interface creates at least a substantial seal on or around the nose and/or the mouth of a patient.
  • carbon dioxide gases from expiration can progressively accumulate in the patient interface, which if left over a period of time, can become hazardous to the patient.
  • a washout vent also known as a bias flow vent
  • a bias flow vent which enables a flow of exhaust gases to be exhausted to the atmosphere from inside the patient interface and which can provide a mechanism for reducing or removing the accumulation of carbon dioxide gases from the patient interface.
  • the vent while providing a mechanism for removing carbon dioxide, can also have disadvantages.
  • the vent can sometimes create a disturbance for the patient and/or the patient's bed partner. This disturbance typically manifests itself in two forms: noise and the creation of an air draft.
  • air drafts/airflow can be minimised by spacing individual vent holes of the vent further apart so that there is less entrainment of air and turbulence.
  • the diffuser material may be constructed for example from a non- woven fabric.
  • Non-woven fabrics are a web or matrix of natural or man-made fibres or strands that have been bonded together at various (usually uniformly repeating) locations.
  • This non- woven fabric may be chemically, thermally or mechanically bonded.
  • the fabric may be mechanically bonded using a needle punching process. Needle punched non- woven fabrics are formed by the repeated insertion of barbed needles into the web or matrix of fibres. This‘entangles’ multiple fibres of the web or matrix such that at least some of the fibres become twisted or entwined or wrapped or overlapped or connected or bonded together at various regions where the needle(s) is inserted. For ease of reference this phenomenon will be referred to throughout this specification as a mechanical‘bond’ or‘interlock’ .
  • auxiliary vent passage(s) may be formed between the vent and the diffuser.
  • auxiliary vent passages serve as a failsafe should the diffuser become blocked and make sure adequate C02 flushing can occur.
  • a further issue can be that the severed or detangled fibres may be drawn into the path of airflow which could block the vent holes and/or at least partially obstruct any auxiliary vent passage(s).
  • the piling on the underside of the diffuser retains water and reduces/blocks the auxiliary vent passage. This can be further complicated by the water tension present which further reduces flow.
  • the obstruction of the vent holes and/or auxiliary vent passage(s) may lead to unsuitable flushing of the exhaled gasses from within the patient interface which may provide a severe risk of suffocation to the patient.
  • the disclosure may broadly be said to consist in a mask assembly for respiratory therapy, comprising:
  • a diffuser material defining a diffusing area sufficient to cover the at least one vent hole and having a periphery
  • a region of the diffusing area of the diffuser material includes a localised joint region in which multiple fibres of the diffuser material are bonded or interlocked together; d. and wherein, the location of the localised joint region is offset from the at least one vent hole.
  • the region of the diffusing area may be a central region of the diffusing material.
  • the central region may:
  • b. extend radially outwardly from the central axis of the vent, in at least one direction.
  • c. extend radially outwardly from the central axis of the vent through 360°, when the vent is viewed in a direction substantially along the axis of at least one vent hole.
  • d. extend in a given direction a distance which is less than 80% of a distance between the central axis and the periphery of the diffuser material, preferably less than 60%, more preferably less than 50% and most preferably less than 40%.
  • the diffuser may have a thickness or depth which extends in a direction along the central axis, and the localised joint region may extend through more than 50% of the thickness or depth of the diffuser material.
  • the localised joint region may extend through the entire thickness of the diffuser material.
  • the localised joint region may be elongate when viewed in a direction substantially along the axis of at least one vent hole.
  • the localised joint section may have a shape when viewed in a direction substantially along the axis of at least one vent hole, the shape being selected from any one of: a. square;
  • the vent may comprise an array of vent holes.
  • the array of vent holes may have a shape when viewed in a direction substantially along the axis of at least one vent hole, the diffuser material comprising an array of a plurality of localised joint regions, both arrays comprising substantially the same peripheral shape.
  • the shape may be substantially:
  • the shape may comprise a pair of sides which incline toward one another, and a top and a base.
  • Any one or more of the sides, top or base may be substantially straight or include a straight portion.
  • Any one or more of the sides, top or base may be substantially arcuate or include an arcuate portion.
  • the shape may be substantially triangular.
  • the mask assembly may comprise a breathing gas inlet aperture having a diameter or width, the length of the base being less than the diameter or width of the breathing gas inlet aperture.
  • the or a localised joint region may be aligned with the central axis.
  • the diffusing area may be sufficient to cover all of the vent holes.
  • the mask assembly may comprise a plurality of spaced apart localised joint regions.
  • the plurality of localised joint regions may be irregularly spaced apart.
  • All of the localised joint regions may be offset from the or each vent hole.
  • the vent may be integrally formed with a mask component of the mask assembly, the diffuser material being mounted on the mask component.
  • the diffuser material may be permanently attached to the mask component.
  • the diffuser material may be removably attached to the mask component.
  • the diffuser material may be attached to a diffuser frame, the diffuser frame being attached to the mask component.
  • the diffuser material may be permanently attached to a diffuser frame.
  • the diffuser frame may be removably attached to the mask component.
  • the mask component may comprise a mask frame, or a mask body or shell.
  • the mask assembly may comprise a plurality of vent holes.
  • the mask assembly may comprise 5 to 15 vent holes.
  • the plurality of vent holes may be in the range of 8 to 40 holes.
  • vent holes There may be two or more groups or arrays of vent holes.
  • Each group or array may comprises 16 vent holes.
  • Each group or array may comprise 32 vent holes.
  • the mask assembly may comprise a plurality of localised joint regions, wherein the plurality is in the range of 3 to 12, 4 to 10, or 6 to 8.
  • the mask assembly may comprise a plurality of vent holes and a plurality of localised joint regions, wherein the mask assembly comprises a diffuser ratio being the ratio of the number of vent holes to the number of localised joint regions
  • the diffuser ratio may be less than 10:1, less than 8:1, less than 5:1, or substantially 4.5:1.
  • the diffuser ratio may be 2:1.
  • the diffuser ratio may be in the range of 3 to 6: 1.
  • the diameter, or distance across the localised joint region may be over 0.5mm, over .75mm, or substantially 1.00mm.
  • the diameter, or distance across the localised joint region may be less than 2.0mm, less than 1.5mm or may be 1.25mm.
  • the total cross sectional area of the localised joint region(s) may be between 2 and 10mm 2 , may be between 3 and 8mm 2 , may be between 4 and 7 mm 2 , and may be about 6.5 mm 2 .
  • the mask assembly may comprise an auxiliary vent formed between the vent and the diffuser material and forming a gases flow path between an interior of the mask assembly and the ambient environment.
  • the auxiliary vent comprises an outlet, the outlet preferably being provided at or near the top of the vent. A direction of gases flow through the auxiliary vent passage is substantially aligned with a longitudinal axis/central plane of the vent, when the vent is oriented in normal use.
  • the localised joint region may be spaced from the periphery of the diffuser material by a distance between 1 and 20mm, may be between 4 and 16mm, and may be between 5 and 12.5mm.
  • the mask assembly may comprise a plurality of localised joint regions, arranged in a group or array, wherein the radially outermost localised joint region is less than 5mm, may be less than 3mm, and in some examples approximately 2mm from the periphery of the diffuser material.
  • the mask assembly may comprise a plurality of spaced apart localised joint regions, wherein the spacing between adjacent localised joint regions is less than 5mm, may be less than 4mm and may be less than 3.5mm.
  • At least one localised joint region may be spaced from a central plane of the vent.
  • the least one localised joint region may be spaced from a central plane of the vent by between 2 and 10mm, may be between 2.5 and 7.5mm, and may be between 3 and 5mm.
  • the periphery of the diffuser material may be mounted on a diffuser frame or surround, the diffuser frame or surround being mounted on the mask assembly.
  • the diffuser frame or surround may comprise a resiliently deformable region which can be resiliently deformed to remove or release the diffuser from the vent or from a position near the vent.
  • the resiliently deformable region may comprise a raised lip or tab in a discrete region of the diffuser frame or surround.
  • the underside of the raised lip or tab may be spaced from a surface of the vent.
  • the raised lip or tab is resiliently deformable such that the raised lip or tab can be elastically deformed towards or away from the auxiliary vent to remove or release the diffuser from the vent.
  • the elastically or resiliently deformable nature of the lip or tab, and the spacing of the lip or tab from the vent surface, may provide a dual mode release mechanism, which allows a user to select whichever movement is most natural or obvious to release the diffuser from the vent.
  • the location of the localised joint region may be offset from the periphery of the diffuser material.
  • the or least one localised joint region may formed from an overmould.
  • the localised joint region may be overmoulded to the diffuser material.
  • the localised joint region may be overmoulded to the diffuser material to space the diffuser from the vent.
  • the disclosure may broadly be said to consist in a mask assembly for respiratory therapy, comprising:
  • a vent for exhausting gas flow including at least two vent holes spaced apart from each other;
  • a diffuser material defining a diffusing area sufficient to cover the at least two vent holes and having a periphery
  • a central region of the diffusing area of the diffuser material includes a localised joint region in which multiple fibres of the diffuser material are bonded together; d. and wherein, the location of the localised joint region is not in the path of the gas flow through the vent holes.
  • a mask assembly for respiratory therapy comprising:
  • a vent for exhausting gas flow including at least two vent holes spaced apart from each other; b. a diffuser material defining a diffusing area sufficient to cover the at least two vent holes, and having a periphery, the periphery having a shape;
  • a central region of the diffusing area of the diffuser material includes a plurality of localised joint regions in each of which multiple fibres of the diffuser material are bonded together;
  • the plurality of localised joint regions are arranged on the diffuser material such that a notional line bounding all of the localised joint regions has a shape which is substantially identical to the shape of the periphery of the diffuser material.
  • the disclosure may broadly be said to consist in a mask assembly for respiratory therapy, comprising:
  • vent for exhausting gas flow, the vent comprising:
  • vent holes spaced apart from each other;
  • a support rib or land configured to protrude from the vent
  • a diffuser material defining a diffusing area sufficient to cover the at least two vent holes and having a periphery
  • the region of the diffuser material includes a localised joint region in which multiple fibres of the diffuser material are bonded together.
  • a mask assembly for respiratory therapy comprising:
  • a vent for exhausting gas flow including at least two vent holes spaced apart from each other;
  • a diffuser material defining a diffusing area sufficient to cover the at least two vent holes and having a periphery
  • a central region of the diffusing area of the diffuser material includes a localised joint region in which multiple fibres of the diffuser material are bonded together; d. the mask assembly further comprising an auxiliary vent passage formed between the vent and the diffuser material and being in communication with both an interior of the mask assembly and the ambient environment.
  • the disclosure may broadly be said to consist in a mask assembly for respiratory therapy, comprising: a. a vent for exhausting gas flow from an interior of the mask assembly, wherein the vent comprises an array of vent holes spaced apart from each other; the array of vent holes having a shape;
  • a diffuser material defining a diffusing area sufficient to cover the array of vent holes, and having a periphery, the periphery having a shape substantially the same as the shape of the array of vent holes;
  • a central region of the diffusing area of the diffuser material includes a plurality of localised joint regions in which multiple fibres of the diffuser material are bonded together;
  • the plurality of localised joint regions includes at least one elongate localised joint region, and a plurality of substantially circular localised joint regions.
  • the disclosure may broadly be said to consist in a diffuser for a mask assembly vent comprising at least one vent hole, the diffuser comprising diffuser material defining a diffusing area sufficient to cover the at least one vent hole and having a periphery;
  • a region of the diffusing area of the diffuser material includes a localised joint region in which multiple fibres of the diffuser material are bonded together;
  • the location of the localised joint region is offset from the at least one vent hole.
  • a mask assembly for respiratory therapy comprising:
  • a vent for exhausting gas flow including at least two vent holes spaced apart from each other;
  • a diffuser material defining a diffusing area sufficient to cover the at least two vent holes and having a periphery
  • the diffusing area of the diffuser material includes a localised joint region in which multiple fibres of the diffuser material are bonded together; the localised joint region being spaced away from the periphery of the diffuser material;
  • the disclosure may broadly be said to consist in a mask assembly for respiratory therapy, comprising:
  • a vent for exhausting gas flow including at least two vent holes spaced apart from each other;
  • a diffuser material defining a diffusing area sufficient to cover the at least two vent holes and having a periphery
  • a central region of the diffusing area of the diffuser material includes a localised joint region in which multiple fibres of the diffuser material are bonded together; d. the mask assembly further comprising an auxiliary vent passage formed between the vent and the diffuser material and being in communication with both an interior of the mask assembly and the ambient environment; and
  • vent has a generally trapezoidal or truncated triangular shape, when viewed from the front of the vent, generally along the axis of the vent holes, having a wider base, and two inclined, opposed, sides which are inclined toward an apex or truncated apex distal from the base.
  • the disclosure may broadly be said to consist in a component of a respiratory therapy system comprising the mask assembly or the diffuser of any one of the above statements.
  • the mask assembly may comprise any one of:
  • an elbow connector configured to connect a gas delivery conduit to a patient interface; b. a gas delivery conduit;
  • a mask frame or shroud configured to be connected to headgear
  • a gas delivery conduit connector configured to connect a gas delivery conduit to another component of the respiratory therapy system.
  • the disclosure may broadly be said to consist in a respiratory therapy system comprising the mask assembly of any one of the above statements and any one or more of:
  • a gas delivery conduit which may or may not be heated
  • the patient interface may be any one of:
  • a nasal interface configured to seal around the nares or nose of the patient
  • an oral mask configured to seal around the mouth of the patient
  • a full face (or oro-nasal) mask configured to seal around both the mouth and nose of the patient.
  • Figure 1 is a perspective view of a respiratory therapy system component being a patient interface on a patient’s head, the patient interface incorporating a vent having a plurality of vent holes/apertures;
  • Figure 2 is a plan view of a mask frame and diffuser in accordance with the present disclosure, in a preassembled condition;
  • Figure 3 is a plan view of the mask frame and diffuser of Figure 2, in an assembled condition
  • Figures 4a-4c are schematic side views of diffuser material
  • Figures 5a and 5b are schematic plan and cross sectional side views of the diffuser of Figures 2 and 3;
  • Figure 6 is a rear view of the vent of the system of Figure 1 and the diffuser of Figures 2 to 5;
  • Figure 7 is an enlarged front view of the vent and part of the mask frame of the system of Figure 1 and the diffuser of Figures 2 to 5;
  • Figure 8 is a front view of the vent and part of the mask frame of the system of Figure 1 and the diffuser of Figures 2 to 5;
  • Figure 9 is an enlarged cross sectional view of the vent and diffuser of Figures 1 to 7;
  • Figure 10 is an enlarged plan view of part of the vent and diffuser of Figures 1 to 8, showing some example dimensions;
  • Figures 11A, 11B are views corresponding to Figure 6, showing example notional areas and notional boundaries of the array of localised joint regions;
  • Figure 12 is an enlarged rear view of a modified vent and diffuser showing overmoulded localised joint regions
  • Figure 13 is a view corresponding to Figure 9, but showing the overmoulded localised joint regions of Figure 12.
  • a patient interface 1 is illustrated on a user U, the patient interface 1 incorporating a vent.
  • the interface 1 can be used in the field of respiratory therapy and therefore in any respiratory treatment, respiratory assistance, resuscitation or ventilation system.
  • the interface 1 has particular utility with forms of positive pressure respiratory therapy.
  • the interface 1 can be used for administering continuous positive airway pressure (“CPAP") treatments, variable positive airway pressure (“VPAP”) treatments and/or bi-level positive airway pressure (“BiPAP”) treatments.
  • CPAP continuous positive airway pressure
  • VPAP variable positive airway pressure
  • BiPAP bi-level positive airway pressure
  • the interface 1 can be compatible with one or more different types of suitable CPAP systems as well as non-invasive ventilation (NIV) systems.
  • NMV non-invasive ventilation
  • the interface 1 can comprise any of a plurality of different types of suitable mask configurations.
  • certain features, aspects and advantages of the present disclosure can be utilized with nasal masks, oral masks, full face masks, oronasal masks or any other positive pressure mask.
  • the illustrated prior art mask is a full face mask, the scope of the present disclosure should not be limited by the particular embodiments described.
  • the interface 1 comprises a mask body 3, a mask frame 5 and a connection port assembly 9.
  • the mask body 3 is configured to cover the user's mouth and/or nose to deliver respiratory gases to the user.
  • the mask body 3 can be secured to the mask frame 5.
  • the mask frame 5 is held in place by a headgear assembly 7 that wraps around a part or parts of the user's head.
  • the connection port assembly 9 can be connected to an inlet aperture 10 of the mask body 3 and/or mask frame 5. In some examples this can be achieved with a releasable connection.
  • the connection port assembly 9 can include a ball joint to improve flexibility and comfort.
  • the connection port assembly 9 in this example comprises an elbow connector 9A, which may include a swivel joint such as a ball joint, configured to be connected between the mask body 3 and/or mask frame 5 and a gas delivery conduit (not shown).
  • the mask frame 5 can couple to the mask body 3 and help stabilize the interface 1 on the user's face.
  • the mask frame 5 can be any shape and size to functionally secure the interface 1 to the user's face.
  • the mask frame 5 may also serve to connect the headgear assembly 7 to the mask body 3.
  • the mask frame 5 can be attached to the mask body 3 with interlocking clips, tabs or other functional couplers and may be releasably or permanently attached.
  • the mask frame 5 can be rigid, substantially rigid or semi-rigid to provide support for the mask body 3.
  • the mask frame 5 can be at least partially made of a metal or rigid plastic, such as acrylic, polycarbonate or high-density polyethylene.
  • the mask frame 5 can extend to the user's forehead and may optionally include a forehead rest 11.
  • the forehead rest 11 can help stabilize the interface 1 to the user's face by providing a support point for the interface 1 and connection points for the headgear assembly 7.
  • a frame bridge 13 extends between the main body of the frame 5 and the forehead rest 11.
  • the frame bridge 13 can be integrally formed or moulded with the rest of the mask frame 5 from the same rigid material.
  • the forehead rest 11 can be a separate flexible piece that is attached or overmoulded onto the mask frame 5.
  • the forehead rest 11 can be made of a flexible silicone that is overmoulded onto the frame bridge 13.
  • the flexible material advantageously conforms to the user's forehead anatomy and helps improve comfort to the user with soft material contact.
  • the forehead rest 11 can be attached or integrally formed as part of the mask frame 5 and can be made of the same material as the mask frame 5 and frame bridge 13.
  • the typical method of passively venting carbon dioxide (C02) and expiratory gases is via the use of a vent comprising a vent hole/ aperture or a vent hole/ aperture array that is incorporated into the mask body or gas path componentry that, for example, is directly connected to the mask.
  • the interface 1 has a vent 15 for expelling gases from inside the mask to the environment.
  • the vent 15 can help expel carbon dioxide gases from the patient interface that have been exhaled from the user into the patient interface, this reduces the rebreathing of the carbon dioxide gases.
  • the vent 15 may be provided in the connection port assembly 9, for example on the elbow connector.
  • the vent 15 creates a controlled or known leak to enable the exhausting of the user's exhaled carbon dioxide gases. There may be a performance trade-off between the location of the vent 15 (relative to the patient's mouth or nose) and the amount of bias flow required.
  • bias flow refers to the flow of gases to the environment through the vent holes of the vent. The flow rate of the bias flow and the design geometry of the vent holes can have an effect on the noise level and draft that the bias flow produces, as well as the amount of entrainment that the exiting gas flow may cause, as discussed further below.
  • the vent 15 comprises a plurality of vent holes 15A on the mask body 3 that expel gases through a cut-out 16 in the mask frame 5.
  • the vent 15 can comprise slits or larger openings instead of or in addition to small through holes.
  • the vent 15 can be disposed on other portions of the interface, such as the connection port assembly 9 or connection joints, as discussed below.
  • relatively smaller vent hole sizes produce less airflow noises compared to a larger vent hole size given the same flow velocity through both hole sizes.
  • the plurality of vent holes helps reduce airflow noises compared to having one or a few holes with the same vent area when expelling a given volume of gas.
  • the vent 15 can be formed as a separate vent component/module from the mask body 3 or mask frame 5.
  • the separate vent module can be permanently or releasably assembled to the mask body 3 or mask frame 5.
  • the vent module can have threads that mate with complementary threads on the mask body 3.
  • the air vent module can have any type of functional coupler or connector to mate the vent module to the mask body 3 or mask frame 5.
  • the vent module may connect with the mask body 3 or mask frame 5 via a snap fit connection for example, or any other form of interference fit. In these configurations, the vent module can be removed easily for service, cleaning or replacement.
  • the vent module can be overmoulded to the mask body 3 or mask frame 5 for a permanent attachment.
  • the overmoulding can include a flexible gusset between the vent module and the mask that helps with flexibility.
  • the vent module can be permanently attached using, for example, adhesives, ultrasonic welding or radio-frequency welding.
  • the vent 15 can be formed of a different material than the mask body 3 or mask frame 5. This can advantageously allow the vent 15 to be made of a material that is more suitable for forming vent holes or apertures.
  • the vent 15 can be made of a soft and/or flexible material while the mask body 3 and/or mask frame 5 are made of a more rigid material.
  • the soft and/or flexible material e.g., silicone, rubber, foam and the like
  • the vent 15 can be formed of the same material as the mask body 3 and/or mask frame 5 while providing acceptable noise and draft levels.
  • the vent 15 can be made of a rigid material while the mask body 3 and/or mask frame 5 are made of a soft and/or flexible material.
  • a separate vent module can allow improved manufacturing and product quality.
  • the vent 15 in a separate component, the moulding of the relatively small and detailed vent holes can be better controlled.
  • the part tolerances can be better controlled and result in more consistent hole dimensions having a more consistent flow rate performance between parts.
  • Moulding a separate vent module may allow for production of more complex vent designs as a result of not having to accommodate undercuts and other geometric restrictions of other components, such as the mask body 3 for example.
  • Improved control of the part dimensions may also improve control of noise levels, such as by controlling the part contours to produce a smooth air- flow through the vent holes.
  • vent 15, and in particular the or each vent hole 15A can be covered by a diffuser 17 comprising diffuser material.
  • the vent 15 has a generally trapezoidal or truncated triangular shape, when viewed from the front of the vent, generally along the axis of the vent holes 15 A, having a wider base 15B, two inclined sides 15C which are inclined toward one another and meet at a narrower top 15D.
  • the base and top 15B, 15D are arcuate; b) the base 15B follows the curve of the inlet aperture 10; c) The sides 15C are substantially straight.
  • the curve of the base 15B is therefore similar to or complements or mirrors or is parallel to at least a portion of the adjacent curve of the inlet aperture 10, with the remainder of the vent 15 tapering upwardly and inwardly away from the inlet aperture 10, with an apex of the vent 15 being distal from the inlet aperture 10, so that the vent 15 is substantially triangular.
  • An array of a plurality of vent holes/apertures 15A is provided within the sides, base and top 5B-15D that define the vent area.
  • the vent holes 15A are substantially equispaced and arranged over the area defined by the vent 15.
  • the outermost vent holes 15A follow the shape defined by the vent base, sides and top 15B to 15D.
  • An auxiliary vent 19 is defined by the profile of the mask frame 5 in the apex region of the vent 15, as is described in more detail below.
  • the diffuser 17 has a shape and geometry, in particular the shape and geometry of the diffuser periphery, which in this example matches the shape of the vent 15.
  • the vent 15 may be recessed into the mask frame 5, so as to define a recessed region in which the diffuser 17 is inserted, with the outer surface of the diffuser flush with the outer surface of the mask frame 5.
  • the shape of the diffuser 17 may be different to the shape of the vent 15.
  • the diffuser 17 comprises a diffuser frame or support 17A to which the diffuser material 17B is mounted.
  • the outer periphery 17C of the diffuser material 17B may comprise a bonded or interlocked region during manufacture of the diffuser material 17B.
  • the cutting of the diffuser material 17B to the shape required may simultaneously bond the periphery 17C of the diffuser material 17B, via the increased temperature of the cutting tool.
  • the bonded periphery 17C of the diffuser material 17B may be mounted on the diffuser frame 17A using any suitable means, which could be via adhesive or overmoulding for example.
  • the diffuser frame 17A may itself be formed by an overmould. In some examples overmoulding the diffuser frame 17A to the diffuser material 17B may form the bonded periphery 17C.
  • a region or regions of the diffuser material 17B are bonded or interlocked together.
  • this region is the periphery or margin 17C of the diffuser material.
  • the present disclosure relates to providing additional regions of bonded or interlocked diffuser material, in the area or spaced contained within the periphery 17C.
  • Figure 4a schematically shows lengths of fibre of the diffuser material 17B extending across the diffuser 15 in normal use.
  • Figure 4b shows what can happen to the lengths of fibre in prior art diffusers, when the diffuser material 17B wears or ages or has been used for some time or otherwise deteriorates or becomes damaged.
  • Figure 4c shows the provision, in accordance with this disclosure, in the diffuser material 17B of at least one localised joint region 17E, between the existing regions of bonded or interlocked diffuser material.
  • the localised joint region 17E comprises a specifically defined and positioned region of the diffuser material 17B which is bonded or interlocked so as to shorten the effective length of at least some of the fibres or strands of the diffuser material 17B, whilst minimising or avoiding any effect on the gas flow performance of the vent 15 and diffuser 17.
  • effective length we mean the length of the fibres or strands between localised joint regions, or between a localised joint region and the periphery of the diffuser material.
  • each localised joint region 17E is positioned so as not to be aligned with any vent hole 15A in a vertical plane, that is, a plane extending through and perpendicular to the diffuser material, and so not to interfere with the gases flow through any vent hole 15 A.
  • the arrangement and location of the localised joint regions 15E is therefore selected in a predetermined manner. For example:
  • the localised joint regions 15E could be positioned in a central location of the vent 15 and diffuser 17 such that the length between un-bonded regions of the maximum number of fibers is reduced.
  • the localised joint regions 17E should not be positioned inline with the vent holes 15A of the vent 15 as this will disrupt airflow and cause undesired restriction through the vent 15, which can lead to excess noise, pressure buildup and/or turbulent flow. This can be achieved by placing the localised joint regions 17E in locations between bias vent holes 15A, or in front of structural components of the bias vent 15 such as ribs, walls, or other structure or mounting locations of the vent 15. [0095] Any one or more of the following properties relating to the localised joint region(s) 17E may be varied or controlled or determined as required:
  • the shape of a notional line extending around the outside of, and contacting, the outermost localised joint regions 17E may be substantially the same as the shape of the periphery 17C of the diffuser 17.
  • notional boundary lines N around the array of localised joint regions 17E, are shown.
  • the notional boundary line N contacts the radially outermost margin of each localised joint region 17E and the shape of the array of localised joint regions 17E is defined accordingly.
  • the notional boundary line N is spaced from the radially outermost margin of each localised joint region 17E.
  • the notional boundary line could intersect a central axis of each localised joint region 17E, or could contact the radially innermost margin of each localised joint region 17E.
  • an example embodiment in accordance with this disclosure is shown, and comprises the following features: a) Eight localised joint regions 17E on the diffuser 17 and 36 vent holes 15A through the vent 15.
  • the eight localised joint regions 17E are located in a central or centralised or middle region 17F of the diffuser 17.
  • Two localised joint regions 17E are positioned in front of a structure on the vent 15, the structure being in a position where there is no airflow to occlude, and the remaining six localised joint regions 17E are located between various bias vent holes 17A.
  • the grouping of the localised joint regions 17E is in a shape that is substantially the same as the shape of the diffuser 15.
  • the shape of the diffuser approximately forms the same shape outline as the localised joint regions 17E.
  • the diffuser material periphery 17C mechanically bonds all fibers around the perimeter of the diffuser 17.
  • the localised joint regions 17E By locating the localised joint regions 17E in a central location the highest, or at least a relatively high, number of fibers are captured and therefore the longest possible, or at least a relatively long, fiber length between bonded regions is reduced with the least additional localised joint regions 17E.
  • the vent structure can be more clearly seen, with the localised joint regions 17E shown in shadow behind for clarity.
  • the vent structure comprises an elongate land or support or rib 15F which projects outwardly from a surface formed by the vent 15.
  • the diffuser material 17B rests on the land or rib 15F which serves to space at least part of the diffuser material 17B from the vent surface.
  • This space forms an auxiliary vent passageway 17A which terminates in the auxiliary vent 19 at the apex of the vent 15.
  • two of the localised joint regions 17E are aligned with, and spaced apart along, the land or rib 15F.
  • the remaining localised joint regions 17E are located in the spaces between adjacent vent holes 15A.
  • the auxiliary vent 19 comprises a pathway formed between the vent 15 and diffuser 17 that allows gas to exit from the vent 15 without passing through the diffuser 17 should the diffuser 17 become at least partially occluded. Severed fibers that extend away from the diffuser material 15B and are caught in the gas flow could block this pathway either on their own or in combination with the moisture they retain.
  • the localized joint regions 17E restrict the possible maximum length of the severed fibers and therefore reduce the likelihoods of the auxiliary vent being obstructed.
  • the diffuser 17 is used in a full face mask and if the vent 15 is occluded the dangers of suffocation from excess C02 are high.
  • the localised joint region(s) 17E overcome or alleviate this issue, noting that in existing nasal masks with a diffuser if the vent or diffuser becomes occluded the patient can always just open their mouth consciously or subconsciously.
  • the localised joint regions 17E substantially reduce the issue of the vent being occluded from severed or detached fibers of the diffuser material 15B, it is believed in such a high risk scenario that providing the auxiliary vent 19 additional is beneficial to patient safety.
  • the auxiliary vent 19 is positioned at the apex of the vent 15, and is configured to vent gases generally upwardly and away from the mouth, nose and eyes of the user, and in a direction substantially aligned with the elongate stem of the mask frame 3.
  • the stem of the mask frame 3 thus shields the user from the vented gas, at least to some degree.
  • the general direction or longitudinal axis of the vent passage defined by the auxiliary vent 19 is orthogonal to the central axis of the inlet aperture 10, and aligned with the central plane CP.
  • the cross section is taken through the central plane CP of the mask assembly and as such two of the eight localised joint regions 17E are seen positioned in front of a structural component of the vent 15. Since the area of the diffuser 17 located in front of this structure is already occluded from vent flow it is a preferred location for at least one, and preferably at least some, of the localized joint regions 17E. This is because there will be no additional disruption to the gas flow characteristics while still providing the desired benefits to the diffuser’s performance and aesthetics.
  • the diffuser surround or frame 17A comprises a resiliently deformable region which forms a raised lip or tab 17G in the region of the auxiliary vent 19.
  • the underside of the raised lip or tab 17G is spaced from the recessed surface of the vent 15 that defines the outlet of the auxiliary vent 19.
  • the raised lip or tab 17G is resiliently deformable such that the raised lip or tab can be elastically deformed towards or away from the auxiliary vent 19. If elastically deformed towards the auxiliary vent 19, the lip or tab 17G pivots the diffuser frame 17A out of the recessed region of the vent 15 in which it sits, to remove the diffuser 17 from the vent 15.
  • the diffuser 17 can be pulled away from the vent, to remove the diffuser 17 from the vent 19.
  • the elastically or resiliently deformable nature of the lip or tab 17G, and the spacing of the lip or tab 17G from the vent surface provides a dual mode release mechanism, which allows a user to select whichever movement is most natural or obvious to release the diffuser 17 from the vent 15.
  • the lip or tab 17G forms an upwardly inclined, thickened, discrete region of the diffuser surround 17A.
  • each localized joint region 17E is approximately 1.00mm and therefor the area is approximately 0.79mm 2 .
  • Absolute refers to the area when viewed in a direction along the central plane CP and generally perpendicular to the surface of the vent 15, in a directional along the direction of flow of gases through the vent holes 15 A.
  • the diameter of each localised joint region is in the range of 0.5-2mm, the area of each localised joint region in the range of 0.3- 1.8 mm 2 , and the total area of localised joint regions in the range of 2- 10 mm 2 .
  • each localised joint region 17E arranged in an array of substantially the same shape as the vent array.
  • the localised joint regions 17E are on centres of between 1 and 2mm, with the localised joint regions 17E being tessellated together with no gap, or only a small gap, between adjacent regions 17E, each localised joint region 17E being offset from the vent apertures 15A, each region 17E being centrally located between three vent apertures 15A.
  • the centres of the regions 17E closest to the lower margin of the vent are between 5.5 and 7mm from that lower margin.
  • the centre of the region 17E furthest from the lower margin of the vent is between 11 and 13mm from that lower margin, and in this example 12.3mm.
  • a localised joint region 17E can be formed by overmoulding OM, that is, by injecting plastic between the fibres of a region of the diffuser material to entangle them.
  • the localised joint region 17E is central and elongate.
  • Elongate land or rib 15F is overmoulded to the vent 15 so that it joins the diffuser fibres and provides a spacer between the vent and the diffuser.
  • This overmoulding OM and land or rib 15F serves to space the diffuser material from the vent 15, and to entangle the fibres of the localised joint region 17E.
  • the shape of the localised joint region 17E matches the shape of the land or rib 15F.
  • the terms“approximately,”“about,” and“substantially” as used herein represent an amount close to the stated amount that still performs a desired function or achieves a desired result.
  • the terms“approximately”,“about”, and“substantially” may refer to an amount that is within less than or equal to 10% of, within less than or equal to 5% of, and within less than or equal to 1% of the stated amount.
  • the disclosed apparatus and systems may also be said broadly to consist in the parts, elements and features referred to or indicated in the specification of the application, individually or collectively, in any or all combinations of two or more of said parts, elements or features.
  • acts, events, or functions of any of the algorithms, methods, or processes described herein can be performed in a different sequence, can be added, merged, or left out altogether (for example, not all described acts or events are necessary for the practice of the algorithms).
  • acts or events can be performed concurrently, for example, through multi-threaded processing, interrupt processing, or multiple processors or processor cores or on other parallel architectures, rather than sequentially.

Landscapes

  • Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Respiratory Apparatuses And Protective Means (AREA)

Abstract

La présente invention concerne un ensemble masque pour une thérapie respiratoire, comprenant : un évent pour évacuer un écoulement de gaz d'un intérieur de l'ensemble masque, l'évent comprenant au moins un trou d'aération ; et un matériau diffuseur délimitant une zone de diffusion suffisante pour recouvrir le trou d'aération et présentant une périphérie. Une région de la zone de diffusion du matériau diffuseur comprend une région d'articulation localisée dans laquelle de multiples fibres du matériau diffuseur sont liées ou verrouillées ensemble. L'emplacement de la région d'articulation localisée est décalé par rapport au trou d'aération. Selon d'autres modes de réalisation, la forme du matériau de diffusion correspond à la forme d'un réseau de trous d'aération, ou présente d'autres propriétés liées au réseau de trous d'aération ou à la forme ou à d'autres caractéristiques de l'évent.
PCT/NZ2019/050154 2018-11-26 2019-11-26 Diffuseur pour composant d'un système de thérapie respiratoire WO2020111951A1 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
SG11202104824UA SG11202104824UA (en) 2018-11-26 2019-11-26 Diffuser for a component of a respiratory therapy system
US17/309,381 US20220023569A1 (en) 2018-11-26 2019-11-26 Diffuser for a component of a respiratory therapy system
EP19890824.6A EP3886957A4 (fr) 2018-11-26 2019-11-26 Diffuseur pour composant d'un système de thérapie respiratoire
AU2019388414A AU2019388414A1 (en) 2018-11-26 2019-11-26 Diffuser for a component of a respiratory therapy system

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862771444P 2018-11-26 2018-11-26
US62/771,444 2018-11-26

Publications (1)

Publication Number Publication Date
WO2020111951A1 true WO2020111951A1 (fr) 2020-06-04

Family

ID=70852070

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/NZ2019/050154 WO2020111951A1 (fr) 2018-11-26 2019-11-26 Diffuseur pour composant d'un système de thérapie respiratoire

Country Status (5)

Country Link
US (1) US20220023569A1 (fr)
EP (1) EP3886957A4 (fr)
AU (1) AU2019388414A1 (fr)
SG (1) SG11202104824UA (fr)
WO (1) WO2020111951A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023237456A1 (fr) * 2022-06-10 2023-12-14 Koninklijke Philips N.V. Agencement de diffuseur d'échappement et masque cpap le comprenant

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5097236A (en) * 1989-05-02 1992-03-17 Murata Manufacturing Co., Ltd. Parallel connection multi-stage band-pass filter
WO2014015382A1 (fr) 2012-07-27 2014-01-30 Resmed Limited Interface patient et son procédé de production
WO2016072868A1 (fr) * 2014-11-07 2016-05-12 Fisher & Paykel Healthcare Limited Appareil respiratoire
US20170065786A1 (en) * 2014-05-09 2017-03-09 Fisher & Paykel Healthcare Limited Diffuser arrangements for a vent of a respiratory interface
US20170281898A1 (en) * 2014-09-18 2017-10-05 Resmed Limited Gas without vent for patient interface
WO2018009080A1 (fr) 2016-07-08 2018-01-11 Fisher & Paykel Healthcare Limited Évent pour un composant d'un système de thérapie respiratoire
WO2018085889A1 (fr) * 2016-11-11 2018-05-17 Resmed Asia Operations Pty Ltd Évent d'expiration de gaz pour interface de patient
US10543333B2 (en) * 2007-08-24 2020-01-28 ResMed Pty Ltd Mask vent

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG10202009007RA (en) * 2016-03-15 2020-10-29 Fisher & Paykel Healthcare Ltd Respiratory mask system
CN112703029A (zh) * 2018-09-12 2021-04-23 费雪派克医疗保健有限公司 用于呼吸患者接口的鼻部密封件

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5097236A (en) * 1989-05-02 1992-03-17 Murata Manufacturing Co., Ltd. Parallel connection multi-stage band-pass filter
US10543333B2 (en) * 2007-08-24 2020-01-28 ResMed Pty Ltd Mask vent
WO2014015382A1 (fr) 2012-07-27 2014-01-30 Resmed Limited Interface patient et son procédé de production
US20170065786A1 (en) * 2014-05-09 2017-03-09 Fisher & Paykel Healthcare Limited Diffuser arrangements for a vent of a respiratory interface
US20170281898A1 (en) * 2014-09-18 2017-10-05 Resmed Limited Gas without vent for patient interface
WO2016072868A1 (fr) * 2014-11-07 2016-05-12 Fisher & Paykel Healthcare Limited Appareil respiratoire
WO2018009080A1 (fr) 2016-07-08 2018-01-11 Fisher & Paykel Healthcare Limited Évent pour un composant d'un système de thérapie respiratoire
WO2018085889A1 (fr) * 2016-11-11 2018-05-17 Resmed Asia Operations Pty Ltd Évent d'expiration de gaz pour interface de patient

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP3886957A4

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023237456A1 (fr) * 2022-06-10 2023-12-14 Koninklijke Philips N.V. Agencement de diffuseur d'échappement et masque cpap le comprenant

Also Published As

Publication number Publication date
AU2019388414A1 (en) 2021-05-27
SG11202104824UA (en) 2021-06-29
EP3886957A4 (fr) 2022-08-17
EP3886957A1 (fr) 2021-10-06
US20220023569A1 (en) 2022-01-27

Similar Documents

Publication Publication Date Title
US20210260321A1 (en) Mask vent
US11517698B2 (en) Nasal prongs for mask system
AU2017293759B2 (en) A vent for a component of a respiratory therapy system
EP2979719B1 (fr) Appareil d'expiration pour une interface patient
US10926049B2 (en) Patient interface device with frame and clips
EP2844322B1 (fr) Interface nasale à utiliser avec un système de pression des voies nasales
WO2012107858A1 (fr) Dispositif d'interface patient pourvu d'un casque, procurant une administration et un écoulement gazeux intégré
US20220023569A1 (en) Diffuser for a component of a respiratory therapy system
CN116322851A (zh) 用于患者接口设备的排气装置和包括该装置的患者接口
CN216777696U (zh) 排气组件及呼吸面罩
WO2015110605A1 (fr) Masque respiratoire ayant une entrée de gaz ondulée
CN212118732U (zh) 低噪音呼吸面罩
CN113893424A (zh) 排气组件及呼吸面罩
CN206809523U (zh) 一种呼吸面罩头带、呼吸面罩头带组件及呼吸面罩
EP3174587B1 (fr) Conduit de couplage de fluide pour un dispositif d'interface patient
EP3470103A1 (fr) Raccord coudé pour masque respiratoire comportant une structure maillée pour évacuer le gaz expiré par le patient
CN103476446B (zh) 面罩通气口
NZ708938B2 (en) Mask Vent
NZ737320B2 (en) Mask Vent
NZ737320A (en) Mask vent
NZ753228B2 (en) Mask Vent

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 19890824

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2019388414

Country of ref document: AU

Date of ref document: 20191126

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2019890824

Country of ref document: EP

Effective date: 20210628